Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 6
2004 7
2005 10
2006 7
2007 7
2008 11
2009 8
2010 18
2011 19
2012 20
2013 20
2014 13
2015 18
2016 27
2017 22
2018 18
2019 22
2020 24
2021 23
2022 28
2023 22
2024 17
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

333 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic relevance of the neurological symptom burden in brain metastases from breast cancer.
Steindl A, Zach C, Berchtold L, Grisold A, Gatterbauer B, Eckert F, Bago-Horvath Z, Hainfellner JA, Exner R, Fitzal F, Pfeiler G, Singer CF, Widhalm G, Bartsch R, Preusser M, Berghoff AS. Steindl A, et al. Among authors: singer cf. Br J Cancer. 2025 Mar 1. doi: 10.1038/s41416-025-02967-w. Online ahead of print. Br J Cancer. 2025. PMID: 40025253
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials.
Wimmer K, Hlauschek D, Balic M, Pfeiler G, Greil R, Singer CF, Halper S, Steger G, Suppan C, Gampenrieder SP, Helfgott R, Egle D, Filipits M, Jakesz R, Sölkner L, Fesl C, Gnant M, Fitzal F; Austrian Breast & Colorectal Cancer Study Group. Wimmer K, et al. Among authors: singer cf. Breast. 2025 Apr;80:104415. doi: 10.1016/j.breast.2025.104415. Epub 2025 Feb 19. Breast. 2025. PMID: 39985843 Free PMC article. Clinical Trial.
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial.
Rinnerthaler G, Egle D, Bartsch R, Schmitt CA, Petzer A, Balic M, Petru E, Denison U, Singer CF, Bjelic-Radisic V, Gampenrieder SP, Knauer M, Sotlar K, Brunner C, Posch F, Hlauschek D, Sölkner L, Bago-Horvath Z, Filipits M, Gili M, Ritter M, Wieser V, Albertini C, Zaborsky N, Weiss L, Marhold M, Schneeweiss B, Pusch R, Gnant M, Greil R. Rinnerthaler G, et al. Among authors: singer cf. Nat Cancer. 2025 Jan;6(1):41-50. doi: 10.1038/s43018-024-00890-2. Epub 2025 Jan 16. Nat Cancer. 2025. PMID: 39820125 Free PMC article. Clinical Trial.
HER2 and HER3 expression during neoadjuvant treatment of HER2-negative early breast cancer: potential for biomarker-driven sequencing of T-DXd and HER3-DXd.
Singer CF, Jahn SW, Hlauschek D, Heber UM, Mang-Manger C, Egle D, Balic M, Pichler A, Pfeiler G, Kacerovsky-Strobl S, Suppan C, Ritter M, Petru E, Greil R, Bago-Horvath Z, Deutschmann C, Steger GG, Seifert M, Fitzal F, Bartsch R, Santhanagopal A, Machacek-Link J, Sellami D, Schwarz M, Fesl C, Sölkner L, Esker S, Filipits M, Gnant M; Austrian Breast and Colorectal Cancer Study Group. Singer CF, et al. Cancer Commun (Lond). 2025 Jan 6. doi: 10.1002/cac2.12657. Online ahead of print. Cancer Commun (Lond). 2025. PMID: 39757921 No abstract available.
The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation.
Katona BW, Lubinski J, Pal T, Huzarski T, Foulkes WD, Moller P, Eisen A, Randall Armel S, Neuhausen SL, Raj R, Aeilts A, Singer CF, Bordeleau L, Karlan B, Olopade O, Tung N, Zakalik D, Kotsopoulos J, Fruscio R, Eng C, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Katona BW, et al. Among authors: singer cf. Cancer. 2025 Jan 1;131(1):e35666. doi: 10.1002/cncr.35666. Epub 2024 Nov 29. Cancer. 2025. PMID: 39611336 Free PMC article.
Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine.
Knöbl V, Maier L, Grasl S, Kratzer C, Winkler F, Eder V, Hayden H, Sahagun Cortez MA, Sachet M, Oehler R, Frantal S, Fesl C, Zehetner K, Pfeiler G, Bartsch R, Fitzal F, Singer CF, Filipits M, Gnant M, Brostjan C. Knöbl V, et al. Among authors: singer cf. J Transl Med. 2024 Oct 8;22(1):913. doi: 10.1186/s12967-024-05659-w. J Transl Med. 2024. PMID: 39380101 Free PMC article.
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109).
Nader-Marta G, Singer C, Hlauschek D, DeMichele A, Tarantino P, de Azambuja E, Pfeiler G, Martin M, Balko JM, Nowecki Z, Balic M, Brufsky AM, Chan A, Morris PG, Haddad T, Loibl S, Liu Y, Soelkner L, Fesl C, Mayer EL, Gnant M; PALLAS groups and investigators. Nader-Marta G, et al. Among authors: singer c. Breast Cancer Res. 2024 Oct 7;26(1):140. doi: 10.1186/s13058-024-01899-2. Breast Cancer Res. 2024. PMID: 39375745 Free PMC article. Clinical Trial.
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2.
Phillips KA, Kotsopoulos J, Domchek SM, Terry MB, Chamberlain JA, Bassett JK, Aeilts AM, Andrulis IL, Buys SS, Cui W, Daly MB, Eisen AF, Foulkes WD, Friedlander ML, Gronwald J, Hopper JL, John EM, Karlan BY, Kim RH, Kurian AW, Lubinski J, Metcalfe K, Nathanson KL, Singer CF, Southey MC, Symecko H, Tung N, Narod SA, Milne RL; Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer, the Risk Factor Analysis of Hereditary Breast and Ovarian Cancer Study, the Basser Center University of Pennsylvania Registry, and the Breast Cancer Family Registry; Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer, the Risk Factor Analysis of Hereditary Breast and Ovarian Cancer Study, the Basser Center University of Pennsylvania Registry and the Breast Cancer Family Registry. Phillips KA, et al. Among authors: singer cf. J Clin Oncol. 2025 Feb;43(4):422-431. doi: 10.1200/JCO.24.00176. Epub 2024 Oct 2. J Clin Oncol. 2025. PMID: 39356978 Free PMC article.
Incidence of endometrial cancer in BRCA mutation carriers.
Kotsopoulos J, Lubinski J, Huzarski T, Bychkovsky BL, Moller P, Kim RH, Tung N, Eisen A, Foulkes W, Singer CF, Aeilts A, Neuhausen SL, Bordeleau L, Karlan B, Fruscio R, Eng C, Olopade O, Zakalik D, Couch F, Y Cajal TR, Sun P, Gronwald J, Narod SA. Kotsopoulos J, et al. Among authors: singer cf. Gynecol Oncol. 2024 Oct;189:148-155. doi: 10.1016/j.ygyno.2024.07.687. Epub 2024 Aug 21. Gynecol Oncol. 2024. PMID: 39173195
333 results